James Jiayuan Tong is Director at TIANYIN PHARMACEUTICAL CO., INC. (TPI). They have made 15 open-market trades across 2 companies since 2010, most recently 2014-12-15.
CIK 0001489785
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
15 open-market purchases totalling $45K since 2010, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PrivateUnlisted | 56,000 | — |
| TPI | 404,066 | — |
| Total | $0 |
Shares reported on the most recent Form 4, priced at the 2015-01-22 close. 2 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TPI | BUY | 2014-05-28 | 2015-01-22 | $0.75 | $2K | N/A | N/A | N/A |
| TPI | BUY | 2014-05-20 | 2014-05-28 | $0.68 | $3K | N/A | N/A | N/A |
| TPI | BUY | 2014-03-07 | 2014-03-14 | $1.07 | $3K | N/A | N/A | N/A |
| TPI | BUY | 2013-06-17 | 2013-07-02 | $0.49 | $4K | N/A | N/A | N/A |
| TPI | BUY | 2013-03-01 | 2013-04-01 | $0.66 | $4K | N/A | N/A | N/A |
| TPI | BUY | 2012-11-26 | 2012-12-11 | $0.64 | $3K | N/A | N/A | N/A |
| TPI | BUY | 2012-06-15 | 2012-06-18 | $0.46 | $874 | N/A | N/A | N/A |
| TPI | BUY | 2012-05-22 | 2012-05-23 | $0.49 | $2K | N/A | N/A | N/A |
| TPI | BUY | 2012-03-14 | 2012-03-14 | $0.85 | $4K | N/A | N/A | N/A |
| TPI | BUY | 2011-11-25 | 2011-11-28 | $0.70 | $5K | N/A | N/A | N/A |
| TPI | BUY | 2011-11-18 | 2011-11-18 | $0.88 | $4K | N/A | N/A | N/A |
| PrivateTIANYIN PHARMACEUTICAL CO., INC. | BUY | 2011-10-12 | 2011-10-13 | $1.18 | $2K | N/A | N/A | N/A |
| TPI | BUY | 2011-10-03 | 2011-10-05 | $1.16 | $2K | N/A | N/A | N/A |
| TPI | BUY | 2011-05-20 | 2011-05-23 | $1.89 | $2K | N/A | N/A | N/A |
| TPI | BUY | 2010-11-23 | 2010-11-23 | $2.97 | $3K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.